Volume 64, Issue 4, Pages (October 2003)

Slides:



Advertisements
Similar presentations
Cyclin-Dependent Kinase 5 Is a Regulator of Podocyte Differentiation, Proliferation, and Morphology Siān V. Griffin, Keiju Hiromura, Jeffrey Pippin, Arndt.
Advertisements

Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
Volume 72, Issue 7, Pages (October 2007)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
F. Guan, G. Villegas, J. Teichman, P. Mundel, A. Tufro 
Volume 72, Issue 3, Pages (August 2007)
Volume 65, Issue 4, Pages (April 2004)
Volume 64, Issue 3, Pages (September 2003)
Volume 59, Issue 3, Pages (March 2001)
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Volume 66, Issue 1, Pages (July 2004)
Volume 67, Issue 5, Pages (May 2005)
Volume 68, Issue 2, Pages (August 2005)
Volume 56, Issue 4, Pages (October 1999)
Volume 77, Issue 11, Pages (June 2010)
Volume 70, Issue 5, Pages (September 2006)
Volume 63, Issue 1, Pages (January 2003)
Mechanical stress reduces podocyte proliferation in vitro
Volume 72, Issue 4, Pages (August 2007)
Volume 63, Issue 1, Pages (January 2003)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Volume 60, Issue 6, Pages (December 2001)
Volume 54, Issue 6, Pages (January 1998)
Mechanical stretch induces podocyte hypertrophy in vitro1
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Mechanisms of the proteinuria induced by Rho GTPases
Volume 63, Issue 1, Pages (January 2003)
Volume 56, Issue 6, Pages (December 1999)
Volume 60, Issue 3, Pages (September 2001)
A new mouse model of immune-mediated podocyte injury
Volume 83, Issue 3, Pages (March 2013)
Volume 62, Issue 4, Pages (October 2002)
Oliver Vonend, Clare M. Turner  Kidney International 
Gene transfer of truncated IκBα prevents tubulointerstitial injury
Erythropoietin stimulates proliferation of human renal carcinoma cells
Volume 60, Issue 6, Pages (December 2001)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 79, Issue 10, Pages (May 2011)
Volume 74, Issue 5, Pages (September 2008)
Volume 69, Issue 6, Pages (March 2006)
Volume 73, Issue 1, Pages (January 2008)
Volume 57, Issue 3, Pages (March 2000)
Volume 56, Issue 4, Pages (October 1999)
Volume 67, Issue 1, Pages (January 2005)
Volume 67, Issue 4, Pages (April 2005)
Volume 77, Issue 8, Pages (April 2010)
Volume 72, Issue 3, Pages (August 2007)
Volume 68, Issue 6, Pages (December 2005)
Volume 62, Issue 5, Pages (November 2002)
Volume 65, Issue 1, Pages (January 2004)
Hongli Lin, Xiangmei Chen, Jianzhong Wang, Zhiheng Yu 
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 72, Issue 7, Pages (October 2007)
Volume 64, Issue 3, Pages (September 2003)
Volume 67, Issue 3, Pages (March 2005)
Volume 64, Pages S21-S26 (October 2003)
Volume 69, Issue 11, Pages (June 2006)
Adenovirus-mediated gene transfer to renal glomeruli in rodents
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
Volume 65, Issue 6, Pages (June 2004)
Volume 64, Issue 3, Pages (September 2003)
Direct effects of dexamethasone on human podocytes
Volume 63, Issue 1, Pages (January 2003)
Volume 57, Issue 4, Pages (April 2000)
Volume 63, Issue 1, Pages (January 2003)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 68, Issue 1, Pages (July 2005)
Volume 65, Issue 6, Pages (June 2004)
Volume 56, Issue 4, Pages (October 1999)
Presentation transcript:

Volume 64, Issue 4, Pages 1222-1231 (October 2003) Podocytes that detach in experimental membranous nephropathy are viable1  Arndt T. Petermann, Ron Krofft, Mary Blonski, Keiju Hiromura, Michael Vaughn, Raimund Pichler, Sian Griffin, Takehiko Wada, Jeffrey Pippin, Raghu Durvasula, Stuart J. Shankland  Kidney International  Volume 64, Issue 4, Pages 1222-1231 (October 2003) DOI: 10.1046/j.1523-1755.2003.00217.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Proteinuria and cell number in passive Heymann nephritis (PHN). (A) There was a sustained increase in 24-hour urinary protein excretion in PHN rats at each time point studied compared to control rats injected with normal sheep serum. *P < 0.001 vs. control (values represent mean ± standard errors). (B) Podocyte number was measured by counting the number of WT-1–positive cells. Podocyte number decreased in PHN rats, but not in controls. *P < 0.001 vs. control. (C) There was a significant correlation between proteinuria and the decrease in podocyte number in PHN rats. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Immunostaining for podocyte antigens in the urine of passive Heymann nephritis (PHN) rats. Immunostaining was not detected when the primary antibody was omitted, which was used as a negative control (A). Immunostaining for WT-1 (B), nephrin (C), and GLEPP1 (D), podocyte-specific antigens, was detected in cells obtained from the urine of PHN rats, but not from controls (not shown). Double immunostaining for Hoechst and C5b-9 (E) and (F), respectively, in cells in the urine from PHN rats show that detached cells stain positive for C5b-9. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Reverse transcription-polymerase chain reaction (RT-PCR) for podocyte antigens in the urine of passive Heymann nephritis (PHN). Total RNA was extracted from the cells obtained in the urine of PHN rats, and subjected to RT-PCR. mRNA expression for WT-1, GLEPP1, nephrin, podocin and synaptopodin (synapo) was detected. RNA from rat kidneys served as positive controls, and replacing the RT mix with H2O served as negative control. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Cells obtained from the urine of passive Heymann nephritis (PHN) rats grow under cell culture conditions. Cells obtained form the urine of PHN rats were resuspended in tissue culture medium, and grown under cell culture conditions. Cells obtained from the urine of three different PHN animals adhered to tissue culture plates at 24 hours ex vivo (A, C, and E). Cells have a typical cobblestone appearance. The same cells at 48 hours ex vivo (taken at the same magnification), and illustrate an increase in cell number, cell size, and mobility (B, D, and F). Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Podocytes were detected in the urine of passive Heymann nephritis (PHN) rats at numerous time points. Urine was collected at different time points from PHN rats (N = 6 each time point), grown under cell culture conditions ex vivo, and total cell number was measured after 24 hours in cell culture on the adherent cells. Although cells were present at day 3, the increase was not statistically significant compared to control. There was a progressive and significant increase in cells obtained from the urine of PHN rats when grown ex vivo, with a peak in animals at day 6 of disease. Although the number declined at days 10 and 20 of disease, the number of cells remained statistically significantly compared to control rats injected with normal sheep serum. *P < 0.01 vs. control. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Cells growing ex vivo stain positive for podocyte-specific markers. Cells obtained from the urine of passive Heymann nephritis (PHN) rats that adhered and grew on tissue culture plates ex vivo stained strongly positive for (A) podocin, (B) nephrin, GLEPP1 (C) and stained weakly for synaptopodin (D). These results show that cells are podocytes. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 mRNA expression for podocyte-specific antigens in cells growing ex vivo. Reverse transcription-polymerase chain reaction (RT-PCR) was performed on total RNA extracted from cells growing ex vivo from PHN rats that had adhered to cell culture plates. mRNA expression was detected for WT-1, GLEPP1, and podocin, but not for nephrin and synaptopodin (synapo). The absence of transcripts were not false negatives, because the primers used detected nephrin and synaptopodin mRNA from normal rat kidney, used as a positive control. The negative control for each reaction comprised omitting the RT product and substituting this with water. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 8 Cell division in an individual multinucleated cell. (A to F) A temporal sequence of phase microscopy every 12 hours of a multinucleated cell dividing under cell culture conditions. Seen is a quadronucleated cell undergoing cytokinesis. Cytokinesis is followed by an increase in cell size and the development of a cell body with primary and secondary processes. Magnification of processes is shown by electron microscopy. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 9 Change of cell number and increase in apoptosis over time. Podocyte colonies were circled and individual cells counted all 12 hours. A peak of cell number is reached at around 72 hours. Decrease in cell number timely correlates with the appearance of apoptotic cells. Kidney International 2003 64, 1222-1231DOI: (10.1046/j.1523-1755.2003.00217.x) Copyright © 2003 International Society of Nephrology Terms and Conditions